Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2012 | 2 |
2013 | 1 |
2014 | 1 |
2015 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease.
Ann Rheum Dis. 2015 Sep;74(9):1714-9. doi: 10.1136/annrheumdis-2013-204877. Epub 2014 Jun 6.
Ann Rheum Dis. 2015.
PMID: 24906637
Free PMC article.
Clinical Trial.
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.
Ruperto N, Quartier P, Wulffraat N, Woo P, Ravelli A, Mouy R, Bader-Meunier B, Vastert SJ, Noseda E, D'Ambrosio D, Lecot J, Chakraborty A, Martini A, Chioato A; Paediatric Rheumatology International Clinical Trials Organisation.
Ruperto N, et al. Among authors: chioato a.
Arthritis Rheum. 2012 Feb;64(2):557-67. doi: 10.1002/art.33342.
Arthritis Rheum. 2012.
PMID: 21953497
Free article.
Clinical Trial.
Item in Clipboard
Bioequivalence of canakinumab liquid pre-filled syringe and reconstituted lyophilized formulations following 150 mg subcutaneous administration: a randomized study in healthy subjects.
Chioato A, Noseda E, Colin L, Matott R, Skerjanec A, Dietz AJ.
Chioato A, et al.
Clin Drug Investig. 2013 Nov;33(11):801-8. doi: 10.1007/s40261-013-0127-4.
Clin Drug Investig. 2013.
PMID: 24030571
Clinical Trial.
Item in Clipboard
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Chioato A, Noseda E, Stevens M, Gaitatzis N, Kleinschmidt A, Picaud H.
Chioato A, et al.
Clin Vaccine Immunol. 2012 Oct;19(10):1597-602. doi: 10.1128/CVI.00386-12. Epub 2012 Aug 8.
Clin Vaccine Immunol. 2012.
PMID: 22875601
Free PMC article.
Clinical Trial.
Item in Clipboard
Influenza and meningococcal vaccinations are effective in healthy subjects treated with the interleukin-1 beta-blocking antibody canakinumab: results of an open-label, parallel group, randomized, single-center study.
Chioato A, Noseda E, Felix SD, Stevens M, Del Giudice G, Fitoussi S, Kleinschmidt A.
Chioato A, et al.
Clin Vaccine Immunol. 2010 Dec;17(12):1952-7. doi: 10.1128/CVI.00175-10. Epub 2010 Oct 20.
Clin Vaccine Immunol. 2010.
PMID: 20962212
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite